<code id='FEBDF8DB13'></code><style id='FEBDF8DB13'></style>
    • <acronym id='FEBDF8DB13'></acronym>
      <center id='FEBDF8DB13'><center id='FEBDF8DB13'><tfoot id='FEBDF8DB13'></tfoot></center><abbr id='FEBDF8DB13'><dir id='FEBDF8DB13'><tfoot id='FEBDF8DB13'></tfoot><noframes id='FEBDF8DB13'>

    • <optgroup id='FEBDF8DB13'><strike id='FEBDF8DB13'><sup id='FEBDF8DB13'></sup></strike><code id='FEBDF8DB13'></code></optgroup>
        1. <b id='FEBDF8DB13'><label id='FEBDF8DB13'><select id='FEBDF8DB13'><dt id='FEBDF8DB13'><span id='FEBDF8DB13'></span></dt></select></label></b><u id='FEBDF8DB13'></u>
          <i id='FEBDF8DB13'><strike id='FEBDF8DB13'><tt id='FEBDF8DB13'><pre id='FEBDF8DB13'></pre></tt></strike></i>

          entertainment

          entertainment

          author:Wikipedia    Page View:61366

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          UnitedHealth starts bidding war with $3.3 billion offer for Amedisys
          UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

          UnitedHealthGroupisattemptingtobuyAmedisysfor$3.3billion.CourtesyUnitedHealthGroupThere’snowatwo-par

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          The science behind Janet Jackson's pregnancy at 49

          JanetJacksonrecentlyannouncedsheispregnantatage49.FrancoisNel/GettyImagesHertourmightbecalledUnstopp